Bixiye
QP68-18 Site of Care Drug Infusion/Injection Program
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Natiijooyinka Raadinta
Soo bandhiga 3121 - 3130 ee natiijooyinka 4919
Bixiye
QP61-18 Availity Authorization Training with Live Demo
Taariikhda barnaamijka Dhaqangalayso Agosto 06, 2018
Bixiye
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Bixiye
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Bixiye
QP28-17 Notification of Provider Submitted Appeals
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 12, 2017
Bixiye
QP60R1-18 Update: Change to Call Center for Transportation for MHCP Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 14, 2018
Bixiye
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016
Bixiye
QP62-18 2018 Fall Blue Cross Basic Seminars to Include Availity Portal Training
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2018
Bixiye
QP56-18 Availity Authorization Portal Update
Taariikhda dhaqangalka Barnaamijka: Jul 18, 2018
Bixiye
QP28-16 Reminders for Providers who Provide Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2016